Cargando…

Thalidomide for the Treatment of Refractory Multiple Myeloma: Association of Plasma Concentrations of Thalidomide and Angiogenic Growth Factors with Clinical Outcome

Recent reports showed that thalidomide has anti‐angiogenic activity and is effective for the treatment of refractory multiple myeloma (MM). We examined the relationship between the clinical efficacy and adverse effects of thalidomide and the plasma concentrations of this drug as well as angiogenic g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kakimoto, Tsunayuki, Hattori, Yutaka, Okamoto, Shinichiro, Sato, Norihide, Kamata, Tamihiro, Yamaguchi, Masaya, Morita, Kunihiko, Yamada, Taketo, Takayama, Nobuyuki, Uchida, Hideo, Shimada, Naoki, Tanigawara, Yusuke, Ikeda, Yasuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927128/ https://www.ncbi.nlm.nih.gov/pubmed/12359057 http://dx.doi.org/10.1111/j.1349-7006.2002.tb02480.x

Ejemplares similares

Elevated Level of Plasma Basic Fibroblast Growth Factor in Multiple Myeloma Correlates with Increased Disease Activity
por: Sato, Norihide, et al.
Publicado: (2002)

Thalidomide—Then and Now: Case Report of a Woman With Thalidomide Embryopathy and Review of Current Thalidomide Uses
por: Malik, Sara, et al.
Publicado: (2021)

Rethinking thalidomide.
Publicado: (1995)

Thalidomide and neurotrophism
por: Soper, Judith R., et al.
Publicado: (2018)

Thalidomide in Dermatology: Revisited
por: Hassan, Iffat, et al.
Publicado: (2015)

Death and Rebirth of the Thalidomide Molecule: A Case of Thalidomide-Induced Sensory Neuropathy
por: Kesserwani, Hassan
Publicado: (2021)

Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects
por: Dredge, K, et al.
Publicado: (2002)

PHARMACEUTICALS: New Insights into Thalidomide
por: Brown, Valerie J.
Publicado: (2009)

Therapy of Angiosarcoma with Thalidomide and Lenalidomide
por: Mattes, M. Jules, et al.
Publicado: (2021)

A history of thalidomide in India
por: Wimmelbücker, Ludger, et al.
Publicado: (2023)

Beyond Thalidomide - Birth Defects Explained
por: McClure, Neil
Publicado: (2008)

Hailey-Hailey Disease Responding to Thalidomide
por: Nanda, K Bala, et al.
Publicado: (2014)

Thalidomide‐induced teratogenesis: History and mechanisms
por: Vargesson, Neil
Publicado: (2015)

Molecular Mechanisms of the Teratogenic Effects of Thalidomide
por: Asatsuma-Okumura, Tomoko, et al.
Publicado: (2020)

Molecular mechanisms of thalidomide and its derivatives
por: ITO, Takumi, et al.
Publicado: (2020)

Successful treatment with thalidomide for pemphigus vulgaris
por: Zhang, Bingjie, et al.
Publicado: (2020)

Replacing the phthalimide core in thalidomide with benzotriazole
por: Krasavin, Mikhail, et al.
Publicado: (2022)

Thalidomide Inhibits Alternative Activation of Macrophages In Vivo and In Vitro: A Potential Mechanism of Anti-Asthmatic Effect of Thalidomide
por: Lee, Hyun Seung, et al.
Publicado: (2015)

Tumour-incidence in progeny of thalidomide-treated mice.
por: Roe, F. J., et al.
Publicado: (1967)

Is the Low-Thalidomide Dose MPT Regimen Beneficial?
por: Min, Chang-Ki
Publicado: (2011)

Thalidomide Prevents the Progression of Peritoneal Fibrosis in Mice
por: Arai, Hideyuki, et al.
Publicado: (2011)

Nitric oxide rescues thalidomide mediated teratogenicity
por: Siamwala, Jamila H., et al.
Publicado: (2012)

The penumbra of thalidomide, the litigation culture and the licensing of pharmaceuticals
por: Lachmann, P.J.
Publicado: (2012)

Thalidomide and its analogues in the treatment of Multiple Myeloma
por: Latif, Tahir, et al.
Publicado: (2012)

Thalidomide for tocilizumab-resistant ascites with TAFRO syndrome
por: Tatekawa, Shotaro, et al.
Publicado: (2015)

Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
por: Saniee, Sara, et al.
Publicado: (2016)

Rosai-Dorfman disease successfully treated with thalidomide
por: Chen, Edward, et al.
Publicado: (2016)

Thalidomide for inflammatory bowel disease: Systematic review
por: Bramuzzo, Matteo, et al.
Publicado: (2016)

Structural basis of thalidomide enantiomer binding to cereblon
por: Mori, Tomoyuki, et al.
Publicado: (2018)

Thalidomide as an effective treatment for adult multiple xanthogranuloma
por: Debois, Deborah, et al.
Publicado: (2018)

Thalidomide and steroid in the management of erythema nodosum leprosum
por: Mishra, S. R. P. K., et al.
Publicado: (2022)

Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis
por: Dsouza, Nikitha Naomi, et al.
Publicado: (2023)

SAT678 Metabolic Disorders In Thalidomide Embryopathy
por: Tanabe, Akiyo
Publicado: (2023)

Discoid lupus erythematosus of the nail treated with thalidomide
por: Harp, Taylor, et al.
Publicado: (2023)

Review of thalidomide in the treatment of newly diagnosed multiple myeloma
por: Cavallo, Federica, et al.
Publicado: (2007)

Adverse Effects of Thalidomide Administration, in Patients with Myeloma Multiplex?
por: Svetlana Balkanov, Krstevska, et al.
Publicado: (2014)

Thalidomide-induced heart block in a dialysis patient
por: Anwar, Siddiq, et al.
Publicado: (2009)

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia
por: Buscarini, Elisabetta, et al.
Publicado: (2019)

Thalidomide, A Rational Agent for Treatment of Multicentric Reticulohistiocytosis
por: Zinn, Daniel J, et al.
Publicado: (2019)

Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia
por: Chen, Yaocheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5uhusc8idphtn67s61tqcfoecj